55 Stocks Moving In Friday's Mid-Day Session

Gainers

• Sphere 3D Corp. ANY shares jumped 29.9% to $4.47 after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a six-month exclusive right to assume all of Hertford's rights to several bitcoin mining agreements.
• BeyondSpring Inc. BYSI gained 21.7% to $26.41. The company recently announced results from its DUBLIN-3 trial of plinabulin in combination with docetaxel for non-small cell lung cancer which showed the study met its primary endpoint.
• Switch, Inc. SWCH shares climbed 19.9% to $24.36 after the company reported better-than-expected Q2 sales results and issued strong FY21 sales guidance.
• HCI Group, Inc. HCI jumped 18.8% to $116.86 following strong quarterly sales.
• Aurinia Pharmaceuticals Inc. AUPH gained 18.7% to $13.90 after the company reported a sharp rise in Q2 sales.
• LiveRamp Holdings, Inc. RAMP jumped 18% to $45.80 after the company reported better-than-expected Q1 results and issued Q2 2022 and FY22 sales guidance above estimates.
• Flora Growth Corp. FLGC gained 17% to $13.40 after gaining 13% on Thursday.
• Westport Fuel Systems Inc. WPRT rose 16.8% to $4.5699 after the company reported better-than-expected Q2 results.
• Synaptics Incorporated SYNA gained 16.1% to $170.01 after reporting upbeat Q4 results.
• Century Casinos, Inc. CNTY jumped 16% to $13.51 after the company swung to a profit in the second quarter.
• Microvast Holdings, Inc. MVST jumped 15.5% to $12.09 amid increased retail investor interest.
• Caribou Biosciences, Inc. CRBU gained 15.3% to $25.02. The company, last month, priced its IPO at $16 a share.
• SCWorx Corp. WORX gained 13.3% to $2.89.
• Cornerstone OnDemand, Inc. CSOD jumped 13% to $56.42 following strong quarterly results.
• Worksport Ltd. WKSP gained 12.8% to $5.39. Worksport recently started trading on NASDAQ. As part of the process for meeting initial listing requirements, the Company completed a 1-for-20 reverse stock split. It priced its underwritten public offering of 3.3 million units at $5.50 per unit.
• Yelp Inc. YELP rose 12.6% to $41.90 as the company reported a surprise profit for its second quarter, while sales exceeded estimates. The company also raised its FY21 sales guidance.
• Gannett Co., Inc. GCI gained 12.2% to $6.23 following upbeat quarterly results.
• MEDNAX, Inc. MD jumped 10.6% to $33.56 following better-than-expected quarterly earnings.
• Aemetis, Inc. AMTX jumped 10.5% to $9.43. Aemetis reported it has received final permit to build next 21 miles of Phase 2 biogas pipeline.
• CarParts.com, Inc. PRTS gained 10.2% to $18.70 after the company posted strong Q2 results and announced a$30 million buyback.
• The Goodyear Tire & Rubber Company GT jumped 9.4% to $16.69 after reporting upbeat Q2 results.
• ADTRAN, Inc. ADTN gained 8.3% to $23.50. Cowen & Co. upgraded Adtran from Market Perform to Outperform.
• BEST Inc. BEST rose 7.1% to $1.1250. BEST is expected to report Q2 results on August 17, 2021.
• Sensus Healthcare, Inc. SRTS rose 4.8% to $3.71 following strong Q2 results.
• GoPro, Inc. GPRO shares rose 4.7% to $10.54 after the company reported better-than-expected Q2 results.
• Plug Power Inc. PLUG shares rose 4% to $27.03 after the company reported better-than-expected Q2 sales and raised FY21 guidance.

Check out these big penny stock gainers and losers

Losers

• Dicerna Pharmaceuticals, Inc. DRNA shares dipped 36.3% to $24.14 after the company announced top-line results from the PHYOX2 pivotal clinical trial of nedosiran, which is in development as a once-monthly treatment for primary hyperoxaluria. Nedosiran is Dicerna's lead GalXC RNAi therapeutic candidate. The PHYOX2 clinical trial included participants with PH subtypes 1 and 2.
• iCAD, Inc. ICAD fell 31.9% to $10.50 after the company reported worse-than-expected Q2 results.
• Spectrum Pharmaceuticals, Inc. SPPI fell 26.1% to $2.4006 after the company received an FDA Complete Response Letter (CRL) regarding its marketing application for Rolontis (eflapegrastim) for neutropenia (low count of a type of white blood cell) in patients receiving myelosuppressive anti-cancer drugs.
• Quotient Technology Inc. QUOT dropped 25.2% to $8.14 after the company reported a wider-than-expected Q2 loss.
• TrueCar, Inc. TRUE fell 20.5% to $4.14 after the company reported worse-than-expected Q2 earnings.
• ViewRay, Inc. VRAY dropped 19.1% to $5.58 following bigger-than-expected loss.
• Novavax, Inc. NVAX fell 18.2% to $193.30 after the company reported that it will delay its submission for an emergency use authorization with the U.S. Food and Drug Administration to the fourth quarter of 2021. The company also reported a wider-than-expected loss for its second quarter.
• Collegium Pharmaceutical, Inc. COLL dropped 18.1% to $20.34 following Q2 results. Cantor Fitzgerald downgraded Collegium Pharmaceutical from Overweight to Neutral and lowered the price target from $30 to $22.
• Zynga Inc. ZNGA fell 17.6% to $8.06 after the company reported worse-than-expected Q2 sales. The company also reported a deal to buy StarLark for $525 million in cash and stock.
• FireEye, Inc. FEYE dropped 15.7% to $16.93 fter the company reported worse-than-expected Q2 sales results. Baird downgraded FireEye from Outperform to Neutral and lowered the price target from $24 to $20.
• Progyny, Inc. PGNY fell 15.1% to $46.99 after the company reported worse-than-expected Q2 sales results and issued Q3 guidance below estimates.
• Vimeo, Inc. VMEO dipped 14.6% to $38.52 after the company reported worse-than-expected Q2 EPS.
• Zymergen Inc. ZY fell 14.5% to $12.35. The company recently provided a business update regarding its commercial product pipeline and financial forecast.
• Y-mAbs Therapeutics, Inc. YMAB dropped 14.1% to $32.04 following Q2 results.
• Chembio Diagnostics, Inc. CEMI shares fell 14% to $3.0284 after the company reported worse-than-expected Q2 results.
• Quidel Corporation QDEL dropped 13% to $125.34 after the company reported after the close of the market Thursday that its second-quarter revenues fell 12% Y/Y to $176.6 million, below the consensus of $194.5 million.
• Covetrus, Inc. CVET fell 12.7% to $22.08 following Q2 results.
• JFrog Ltd. FROG dropped 12.6% to $40.17 after the company issued Q3 and FY21 EPS guidance below estimates.
• Universal Display Corporation OLED dropped 12.4% to $204.68 after the company reported worse-than-expected Q2 EPS results.
• BigCommerce Holdings, Inc. BIGC declined 11.6% to $63.08 after the company reported worse-than-expected Q2 EPS.
• AngloGold Ashanti Limited AU fell 11.3% to $17.02 after dropping 4% on Thursday. RBC Capital maintained Anglogold Ashanti with a Sector Perform and lowered the price target from $22 to $20.
• Redfin Corporation RDFN fell 10.6% to $54.27 following Q2 results.
• AppLovin Corporation APP dropped 9.7% to $57.11.
• Groupon, Inc. GRPN fell 8.3% to $32.69 following Q2 results.
• Baosheng Media Group Holdings Limited BAOS shares fell 8.3% to $2.3107 after surging 17% on Thursday.
• Expedia Group, Inc. EXPE fell 8.3% to $148.14 after the company reported worse-than-expected Q2 EPS results.
• Windtree Therapeutics, Inc. WINT fell 6.8% to $1.8823 after the company reported a wider quarterly loss.
• Asensus Surgical, Inc. ASXC shares fell 5.6% to $2.2275 following downbeat quarterly sales.
• Cloudflare, Inc. NET fell 4.3% to $116.22 after reporting Q2 results.